Home Cart 0 Sign in  
X

[ CAS No. 577-56-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 577-56-0
Chemical Structure| 577-56-0
Chemical Structure| 577-56-0
Structure of 577-56-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 577-56-0 ]

Related Doc. of [ 577-56-0 ]

Alternatived Products of [ 577-56-0 ]

Product Details of [ 577-56-0 ]

CAS No. :577-56-0 MDL No. :MFCD00002475
Formula : C9H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :QDAWXRKTSATEOP-UHFFFAOYSA-N
M.W : 164.16 Pubchem ID :68474
Synonyms :

Calculated chemistry of [ 577-56-0 ]

Physicochemical Properties

Num. heavy atoms : 12
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.11
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.6
TPSA : 54.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.15
Log Po/w (XLOGP3) : 0.81
Log Po/w (WLOGP) : 1.59
Log Po/w (MLOGP) : 1.28
Log Po/w (SILICOS-IT) : 1.55
Consensus Log Po/w : 1.28

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.61
Solubility : 4.07 mg/ml ; 0.0248 mol/l
Class : Very soluble
Log S (Ali) : -1.53
Solubility : 4.81 mg/ml ; 0.0293 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.1
Solubility : 1.31 mg/ml ; 0.00798 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.09

Safety of [ 577-56-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 577-56-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 577-56-0 ]
  • Downstream synthetic route of [ 577-56-0 ]

[ 577-56-0 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 577-56-0 ]
  • [ 5693-27-6 ]
YieldReaction ConditionsOperation in experiment
75%
Stage #1: With hydrogen bromide; bromine; acetic acid In chlorobenzene at 30℃; for 3 h;
Stage #2: With water In chlorobenzene for 3 h; Reflux
Example 2: Preparation of 1 /-/-2-benzopyran-1 ,4(3/-/)-dione (Compound of formula (III))A stirred mixture of 2-acetylbenzoic acid (compound of formula (XI)) (1.00 Kg, 6.09 mol) and chlorobenzene (10.0 L) was treated with 5.5 molar hydrobromic acid in acetic acid (55 ml_) and bromine (310 ml_) then warmed to approximately 30 °C. After 3 hours water (10.0 L) was added and the reaction heated to reflux. After 3 hours the reaction was cooled to 60 °C and the organic layer removed. The aqueous layer was extracted with chlorobenzene (2.0 L) and the combined organic layers concentrated under reduced pressure to approximately 3.0 L. Propan-2-ol (5.0 L) was charged and the slurry cooled to 0 °C before being filtered and washed with propan-2-ol (2.0 L). The resulting solid was dried in vacuo at 50 °C to give the title compound (736 g, 75percent); 1 H NMR (400MHz, CDCI3): δ 5.14 (2H, s, H-9), 7.82 - 7.91 (2H, m, H-2 and 3), 8.08 - 8.10 (1 H, m, H-1), 8.28 - 8.30 (1 H, m, H-4); 13C NMR (100MHz, CDCIs) δ 73.4, 125.6, 128.0, 130.9, 131.8, 134.7, 135.9, 161.4 and 189.5.
63% at 40℃; for 0.5 h; Step 1: lH-Isochromene-l,4(3H)-dione [00369] To a solution of 2-acetylbenzoic acid (8.458 g, 51.52 mmol) in acetic acid (50.0 mL, 879 mmol) was added 30 ml of 33percent HBr in acetic acid. Bromine (8.646 g, 54.10 mmol) was next added to the solution, and the reaction was heated to 40 °C with stirring for 30 min. The reaction mixture was poured into 300 ml water, the layers were separated, and the aqueous layer was extracted with 3 x 100ml DCM. Combined the organic layers and concentrated in vacuo to yield crude intermediate, which was dissolved in 25 ml acetic acid, 130ml toluene and 30 ml water. The resulting mixture was stirred at reflux overnight. The reaction was cooled to rt, and the layers were separated. The organic layer was concentrated in vacuo and purified by flash column ( 120g column, eluent 0-55percent EtOAc in hexane)to afford 5.24g (63percent) of title compound. NMR (400 MHz, Chloroform-d) δ 8.36 - 8.28 (m, 1 H), 8.17 - 8.07 (m, 1 H), 7.95 - 7.79 (m, 2H), 5.16 (s, 2H).
Reference: [1] Patent: WO2012/80243, 2012, A2, . Location in patent: Page/Page column 15-16
[2] Antimicrobial Agents and Chemotherapy, 2017, vol. 61, # 8,
[3] Patent: WO2016/4136, 2016, A1, . Location in patent: Paragraph 00369
[4] Organic Process Research and Development, 2012, vol. 16, # 10, p. 1607 - 1617
  • 2
  • [ 577-56-0 ]
  • [ 5693-27-6 ]
Reference: [1] Organic Process Research and Development, 2012, vol. 16, # 10, p. 1607 - 1617
  • 3
  • [ 577-56-0 ]
  • [ 7726-95-6 ]
  • [ 5693-27-6 ]
Reference: [1] Journal of the Chemical Society, 1963, p. 402 - 410
  • 4
  • [ 577-56-0 ]
  • [ 3453-64-3 ]
  • [ 57259-71-9 ]
  • [ 767-90-8 ]
Reference: [1] Chemistry Letters, 1993, # 9, p. 1495 - 1498
Same Skeleton Products
Historical Records